[Pharmacology and pharmacodynamics of a hypoglycemic sulfonamide very active on insulin secretion and the neogenesis of beta cells of pancreatic Langerhans islets].
D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D004285:Dogs; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007275:Injections, Intravenous; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007441:Intubation, Gastrointestinal; D007515:Islets of Langerhans / Q000033:anatomy & histology / Q000187:drug effects* / Q000378:metabolism; D007801:Langerhans Cells / Q000187:drug effects; D051379:Mice; D009929:Organ Size; D010180:Pancreatectomy; D010477:Perfusion; D012663:Semicarbazides / Q000494:pharmacology*
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D012663:Semicarbazides
Pharmacologie et pharmacodynamie d'un sulfamide hypoglycémiant très actif sur l'insulino-sécrétion et la néogenèse des cellules beta des ilots de Langerhans pancréatiques.